“A distinguished panel of CMIOs, CIOs, analysts, and venture capitalists, along with the editorial panel of Med Tech Outlook has selected Nanovis as a Top 10 Orthopedic Solution Provider, 2019,” said Alex D’souza, Managing Editor of Med Tech Outlook. “We congratulate Nanovis for being at the forefront of providing cutting-edge infection technology solutions; the value these solutions offer to surgeons and hospitals is evident. We anticipate hearing more about the success of Nanovis in the years to come.”

“Nanovis is honored to be recognized by MedTech Outlook,” says Nanovis CEO Matt Hedrick. “Recognition of our technology platforms for fixation and infection is an honor that our scientists and our surgeon collaborators are grateful to accept.”

Nanovis’ fixation technology platforms continue to perform well commercially and in testing. The FortiCore interbody system with a deeply porous titanium scaffold, intermolded with a PEEK core is attractive to surgeons who want deep porosity and the visualization and modulus benefits of PEEK. Nanovis will soon reveal favorable testing results from comparison tests of their nanotube-bioceramic surface compared to non-nanorough titanium, acid-etched nanorough titanium and calcium phosphate coated titanium.

Chris currently serves as Chief Executive Officer of Surgio Health as well as Chief Operating Officer at Ortho Spine Partners.
Prior to that, he was the assistant vice president and business unit leader of Medical Device Management for HealthTrust Purchasing Group (HPG).